0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Covered Biliary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-17I17995
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Covered Biliary Stent System Market Research Report 2024
BUY CHAPTERS

Global Covered Biliary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17I17995
Report
October 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Covered Biliary Stent System Market

The global Covered Biliary Stent System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Public Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Covered Biliary Stent System leading manufacturers including BD, Medtronic, ALLIUM, Boston Scientific, Taewoong Medical, Cook Medical, Gore Medical, BIOTRONIK AG, etc., dominate supply; the top five capture approximately % of global revenue, with BD leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Covered Biliary Stent System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Covered Biliary Stent System Market Report

Report Metric Details
Report Name Covered Biliary Stent System Market
Segment by Type
  • Fully Coated Type
  • Partially Coated Type
Segment by Application
  • Public Hospital
  • Private Hospital
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Medtronic, ALLIUM, Boston Scientific, Taewoong Medical, Cook Medical, Gore Medical, BIOTRONIK AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Covered Biliary Stent System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Covered Biliary Stent System Market report?

Ans: The main players in the Covered Biliary Stent System Market are BD, Medtronic, ALLIUM, Boston Scientific, Taewoong Medical, Cook Medical, Gore Medical, BIOTRONIK AG

What are the Application segmentation covered in the Covered Biliary Stent System Market report?

Ans: The Applications covered in the Covered Biliary Stent System Market report are Public Hospital, Private Hospital

What are the Type segmentation covered in the Covered Biliary Stent System Market report?

Ans: The Types covered in the Covered Biliary Stent System Market report are Fully Coated Type, Partially Coated Type

1 Study Coverage
1.1 Introduction to Covered Biliary Stent System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Covered Biliary Stent System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Fully Coated Type
1.2.3 Partially Coated Type
1.3 Market Segmentation by Application
1.3.1 Global Covered Biliary Stent System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Covered Biliary Stent System Revenue Estimates and Forecasts 2020-2031
2.2 Global Covered Biliary Stent System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Covered Biliary Stent System Sales Estimates and Forecasts 2020-2031
2.4 Global Covered Biliary Stent System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Covered Biliary Stent System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Covered Biliary Stent System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Fully Coated Type Market Size by Manufacturers
3.5.2 Partially Coated Type Market Size by Manufacturers
3.6 Global Covered Biliary Stent System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Covered Biliary Stent System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Covered Biliary Stent System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Covered Biliary Stent System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Covered Biliary Stent System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Covered Biliary Stent System Sales and Revenue by Type (2020-2031)
6.4 North America Covered Biliary Stent System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Covered Biliary Stent System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Covered Biliary Stent System Sales and Revenue by Type (2020-2031)
7.4 Europe Covered Biliary Stent System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Covered Biliary Stent System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Covered Biliary Stent System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Covered Biliary Stent System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Covered Biliary Stent System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Covered Biliary Stent System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Covered Biliary Stent System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Covered Biliary Stent System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Covered Biliary Stent System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Covered Biliary Stent System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Covered Biliary Stent System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Business Overview
11.1.3 BD Covered Biliary Stent System Product Models, Descriptions and Specifications
11.1.4 BD Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BD Covered Biliary Stent System Sales by Product in 2024
11.1.6 BD Covered Biliary Stent System Sales by Application in 2024
11.1.7 BD Covered Biliary Stent System Sales by Geographic Area in 2024
11.1.8 BD Covered Biliary Stent System SWOT Analysis
11.1.9 BD Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Covered Biliary Stent System Product Models, Descriptions and Specifications
11.2.4 Medtronic Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Covered Biliary Stent System Sales by Product in 2024
11.2.6 Medtronic Covered Biliary Stent System Sales by Application in 2024
11.2.7 Medtronic Covered Biliary Stent System Sales by Geographic Area in 2024
11.2.8 Medtronic Covered Biliary Stent System SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 ALLIUM
11.3.1 ALLIUM Corporation Information
11.3.2 ALLIUM Business Overview
11.3.3 ALLIUM Covered Biliary Stent System Product Models, Descriptions and Specifications
11.3.4 ALLIUM Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 ALLIUM Covered Biliary Stent System Sales by Product in 2024
11.3.6 ALLIUM Covered Biliary Stent System Sales by Application in 2024
11.3.7 ALLIUM Covered Biliary Stent System Sales by Geographic Area in 2024
11.3.8 ALLIUM Covered Biliary Stent System SWOT Analysis
11.3.9 ALLIUM Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Corporation Information
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Covered Biliary Stent System Product Models, Descriptions and Specifications
11.4.4 Boston Scientific Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Boston Scientific Covered Biliary Stent System Sales by Product in 2024
11.4.6 Boston Scientific Covered Biliary Stent System Sales by Application in 2024
11.4.7 Boston Scientific Covered Biliary Stent System Sales by Geographic Area in 2024
11.4.8 Boston Scientific Covered Biliary Stent System SWOT Analysis
11.4.9 Boston Scientific Recent Developments
11.5 Taewoong Medical
11.5.1 Taewoong Medical Corporation Information
11.5.2 Taewoong Medical Business Overview
11.5.3 Taewoong Medical Covered Biliary Stent System Product Models, Descriptions and Specifications
11.5.4 Taewoong Medical Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Taewoong Medical Covered Biliary Stent System Sales by Product in 2024
11.5.6 Taewoong Medical Covered Biliary Stent System Sales by Application in 2024
11.5.7 Taewoong Medical Covered Biliary Stent System Sales by Geographic Area in 2024
11.5.8 Taewoong Medical Covered Biliary Stent System SWOT Analysis
11.5.9 Taewoong Medical Recent Developments
11.6 Cook Medical
11.6.1 Cook Medical Corporation Information
11.6.2 Cook Medical Business Overview
11.6.3 Cook Medical Covered Biliary Stent System Product Models, Descriptions and Specifications
11.6.4 Cook Medical Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Cook Medical Recent Developments
11.7 Gore Medical
11.7.1 Gore Medical Corporation Information
11.7.2 Gore Medical Business Overview
11.7.3 Gore Medical Covered Biliary Stent System Product Models, Descriptions and Specifications
11.7.4 Gore Medical Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Gore Medical Recent Developments
11.8 BIOTRONIK AG
11.8.1 BIOTRONIK AG Corporation Information
11.8.2 BIOTRONIK AG Business Overview
11.8.3 BIOTRONIK AG Covered Biliary Stent System Product Models, Descriptions and Specifications
11.8.4 BIOTRONIK AG Covered Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 BIOTRONIK AG Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Covered Biliary Stent System Industry Chain
12.2 Covered Biliary Stent System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Covered Biliary Stent System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Covered Biliary Stent System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Covered Biliary Stent System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Covered Biliary Stent System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Covered Biliary Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Covered Biliary Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Covered Biliary Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Covered Biliary Stent System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Covered Biliary Stent System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Covered Biliary Stent System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Covered Biliary Stent System Sales by Region (2020-2025) & (K Units)
 Table 8. Global Covered Biliary Stent System Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Covered Biliary Stent System Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Covered Biliary Stent System Sales Share by Manufacturers (2020-2025)
 Table 12. Global Covered Biliary Stent System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Covered Biliary Stent System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Covered Biliary Stent System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covered Biliary Stent System as of 2024)
 Table 16. Global Covered Biliary Stent System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Covered Biliary Stent System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Covered Biliary Stent System Manufacturing Base and Headquarters
 Table 19. Global Covered Biliary Stent System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Covered Biliary Stent System Sales by Type (2020-2025) & (K Units)
 Table 23. Global Covered Biliary Stent System Sales by Type (2026-2031) & (K Units)
 Table 24. Global Covered Biliary Stent System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Covered Biliary Stent System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Covered Biliary Stent System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Covered Biliary Stent System Sales by Application (2020-2025) & (K Units)
 Table 29. Global Covered Biliary Stent System Sales by Application (2026-2031) & (K Units)
 Table 30. Covered Biliary Stent System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Covered Biliary Stent System Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Covered Biliary Stent System Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Covered Biliary Stent System ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Covered Biliary Stent System Growth Accelerators and Market Barriers
 Table 37. North America Covered Biliary Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Covered Biliary Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Covered Biliary Stent System Growth Accelerators and Market Barriers
 Table 40. Europe Covered Biliary Stent System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Covered Biliary Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Covered Biliary Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Covered Biliary Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Covered Biliary Stent System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Covered Biliary Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Covered Biliary Stent System Investment Opportunities and Key Challenges
 Table 47. Central and South America Covered Biliary Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Covered Biliary Stent System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Covered Biliary Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. BD Corporation Information
 Table 51. BD Description and Major Businesses
 Table 52. BD Product Models, Descriptions and Specifications
 Table 53. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. BD Sales Value Proportion by Product in 2024
 Table 55. BD Sales Value Proportion by Application in 2024
 Table 56. BD Sales Value Proportion by Geographic Area in 2024
 Table 57. BD Covered Biliary Stent System SWOT Analysis
 Table 58. BD Recent Developments
 Table 59. Medtronic Corporation Information
 Table 60. Medtronic Description and Major Businesses
 Table 61. Medtronic Product Models, Descriptions and Specifications
 Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Medtronic Sales Value Proportion by Product in 2024
 Table 64. Medtronic Sales Value Proportion by Application in 2024
 Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 66. Medtronic Covered Biliary Stent System SWOT Analysis
 Table 67. Medtronic Recent Developments
 Table 68. ALLIUM Corporation Information
 Table 69. ALLIUM Description and Major Businesses
 Table 70. ALLIUM Product Models, Descriptions and Specifications
 Table 71. ALLIUM Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. ALLIUM Sales Value Proportion by Product in 2024
 Table 73. ALLIUM Sales Value Proportion by Application in 2024
 Table 74. ALLIUM Sales Value Proportion by Geographic Area in 2024
 Table 75. ALLIUM Covered Biliary Stent System SWOT Analysis
 Table 76. ALLIUM Recent Developments
 Table 77. Boston Scientific Corporation Information
 Table 78. Boston Scientific Description and Major Businesses
 Table 79. Boston Scientific Product Models, Descriptions and Specifications
 Table 80. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Boston Scientific Sales Value Proportion by Product in 2024
 Table 82. Boston Scientific Sales Value Proportion by Application in 2024
 Table 83. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 84. Boston Scientific Covered Biliary Stent System SWOT Analysis
 Table 85. Boston Scientific Recent Developments
 Table 86. Taewoong Medical Corporation Information
 Table 87. Taewoong Medical Description and Major Businesses
 Table 88. Taewoong Medical Product Models, Descriptions and Specifications
 Table 89. Taewoong Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Taewoong Medical Sales Value Proportion by Product in 2024
 Table 91. Taewoong Medical Sales Value Proportion by Application in 2024
 Table 92. Taewoong Medical Sales Value Proportion by Geographic Area in 2024
 Table 93. Taewoong Medical Covered Biliary Stent System SWOT Analysis
 Table 94. Taewoong Medical Recent Developments
 Table 95. Cook Medical Corporation Information
 Table 96. Cook Medical Description and Major Businesses
 Table 97. Cook Medical Product Models, Descriptions and Specifications
 Table 98. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Cook Medical Recent Developments
 Table 100. Gore Medical Corporation Information
 Table 101. Gore Medical Description and Major Businesses
 Table 102. Gore Medical Product Models, Descriptions and Specifications
 Table 103. Gore Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Gore Medical Recent Developments
 Table 105. BIOTRONIK AG Corporation Information
 Table 106. BIOTRONIK AG Description and Major Businesses
 Table 107. BIOTRONIK AG Product Models, Descriptions and Specifications
 Table 108. BIOTRONIK AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. BIOTRONIK AG Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Covered Biliary Stent System Product Picture
 Figure 2. Global Covered Biliary Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Fully Coated Type Product Picture
 Figure 4. Partially Coated Type Product Picture
 Figure 5. Global Covered Biliary Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Public Hospital
 Figure 7. Private Hospital
 Figure 8. Covered Biliary Stent System Report Years Considered
 Figure 9. Global Covered Biliary Stent System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Covered Biliary Stent System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Covered Biliary Stent System Revenue Market Share by Region (2020-2031)
 Figure 13. Global Covered Biliary Stent System Sales (2020-2031) & (K Units)
 Figure 14. Global Covered Biliary Stent System Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Covered Biliary Stent System Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Covered Biliary Stent System Sales Volume Market Share in 2024
 Figure 17. Global Covered Biliary Stent System Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Fully Coated Type Revenue Market Share by Manufacturer in 2024
 Figure 20. Partially Coated Type Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Covered Biliary Stent System Sales Market Share by Type (2020-2031)
 Figure 22. Global Covered Biliary Stent System Revenue Market Share by Type (2020-2031)
 Figure 23. Global Covered Biliary Stent System Sales Market Share by Application (2020-2031)
 Figure 24. Global Covered Biliary Stent System Revenue Market Share by Application (2020-2031)
 Figure 25. North America Covered Biliary Stent System Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Covered Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Covered Biliary Stent System Sales Revenue (US$ Million) in 2024
 Figure 28. North America Covered Biliary Stent System Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Covered Biliary Stent System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Covered Biliary Stent System Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Covered Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Covered Biliary Stent System Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Covered Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Covered Biliary Stent System Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Covered Biliary Stent System Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Covered Biliary Stent System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Covered Biliary Stent System Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Covered Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 43. France Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Covered Biliary Stent System Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Covered Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Covered Biliary Stent System Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Covered Biliary Stent System Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Covered Biliary Stent System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Covered Biliary Stent System Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Covered Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 58. India Covered Biliary Stent System Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Covered Biliary Stent System Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Covered Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Covered Biliary Stent System Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Covered Biliary Stent System Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Covered Biliary Stent System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Covered Biliary Stent System Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Covered Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Covered Biliary Stent System Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Covered Biliary Stent System Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Covered Biliary Stent System Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Covered Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Covered Biliary Stent System Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Covered Biliary Stent System Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Covered Biliary Stent System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Covered Biliary Stent System Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Covered Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Covered Biliary Stent System Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Covered Biliary Stent System Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Covered Biliary Stent System Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Covered Biliary Stent System Revenue (2020-2025) & (US$ Million)
 Figure 79. Covered Biliary Stent System Industry Chain Mapping
 Figure 80. Regional Covered Biliary Stent System Manufacturing Base Distribution (%)
 Figure 81. Global Covered Biliary Stent System Production Market Share by Region (2020-2031)
 Figure 82. Covered Biliary Stent System Production Process
 Figure 83. Regional Covered Biliary Stent System Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS